OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of ILC2s through constitutive IFNγ signaling reduction leads to spontaneous pulmonary fibrosis
Natsuko Otaki, Yasutaka Motomura, Tommy Terooatea, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16

Showing 16 citing articles:

Reinventing type 2 immunity in cancer
Marek Wagner, Hiroyoshi Nishikawa, Shigeo Koyasu
Nature (2025) Vol. 637, Iss. 8045, pp. 296-303
Closed Access | Times Cited: 2

Psoriasis may increase the risk of idiopathic pulmonary fibrosis: a two-sample Mendelian randomization study
Lingli Chen, Yujie Wei, Mengjin Hu, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 5

Pulmonary fibrosis: pathogenesis and therapeutic strategies
Jianhai Wang, Kuan Li, De Hao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4

The Importance of Lung Innate Immunity During Health and Disease
Gusty Rizky Teguh Ryanto, Ratoe Suraya, Tatsuya Nagano
Pathogens (2025) Vol. 14, Iss. 1, pp. 91-91
Open Access

Type 2 Innate Lymphoid Cell in Cardiovascular Diseases: Complexities and Potentials
Hefen Sun, Weizhuo Liu, Yu Zhou, et al.
Intensive Care Research (2025)
Open Access

Involvement of lncRNA MIR205HG in idiopathic pulmonary fibrosis and IL-33 regulation via Alu elements
Tsuyoshi Takashima, Chao Zeng, Eitaro Murakami, et al.
JCI Insight (2025) Vol. 10, Iss. 5
Open Access

Immune response against antibiotic-resistant and antibiotic-sensitive staphylococcus aureus in a rat model of implant infection
Yingfang Fan, Amita Sekar, Madeline McCanne, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Dysfunction of type 1 and type 2 immune cells: a lesson from exhausted-like ILC2s and their activation-induced cell death
Takashi Ebihara, Toshiki Yamada, Akane Fuchimukai, et al.
International Immunology (2024) Vol. 36, Iss. 11, pp. 585-594
Open Access | Times Cited: 2

Tetrahedral Framework Nucleic Acids Delivery of Pirfenidone for Anti-Inflammatory and Antioxidative Effects to Treat Idiopathic Pulmonary Fibrosis
Yuting Xie, Sirong Shi, Weitong Lv, et al.
ACS Nano (2024) Vol. 18, Iss. 39, pp. 26704-26721
Closed Access | Times Cited: 1

Research Progress on Pathogenesis and Related Factors of Interstitial Lung Disease Associated with Connective Tissue Disease
天晓 崔
Advances in Clinical Medicine (2024) Vol. 14, Iss. 04, pp. 1675-1681
Closed Access

The beneficial effects of Akkermansia muciniphila and its derivatives on pulmonary fibrosis
Shahrbanoo Keshavarz Aziziraftar, Reza Bahrami, Danial Hashemi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117571-117571
Closed Access

Immune-Epithelial Cell Interactions in Lung Development, Homeostasis and Disease
Masahiro Yoshida, Romina Arzili, Marko Nikolić
The International Journal of Biochemistry & Cell Biology (2024) Vol. 178, pp. 106703-106703
Closed Access

Innovation through imitation: IL-33 decoys show promise in pulmonary fibrosis
Maya E. Kotas, Erin D. Gordon
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 1, pp. 100035-100035
Closed Access

Page 1

Scroll to top